Author:
Rehling Michael,Nielsen Bente V.,Pedersen Erling B.,Nielsen Lene E.,Hansen Hans E.,Bacher Theis
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference14 articles.
1. Eshima D, Taylor A Jr. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new99mTc renal tubular function agent.Semin Nucl Med 1992; 22: 61–73.
2. Rehling M, Frøkiær J, Poulsen EU, Marqversen J, Nielsen BV, Bacher T.99mTc-MAG3 kinetics in the normal pig. A comparison to131I-OIH and125I-iothalamate after single injection and during continuous infusion.Clin Physiol 1994: 15: 57–71.
3. Taylor A Jr, Eshima D, Christian PE, Milton W. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.Radiology 1987; 162: 365–370.
4. Bubeck B, Brandau W, Weber E, Kälble T, Parekh N, Georgi P. Pharmacokinetics of technetium-99m-MAG3 in humans.J Nucl Med 1990; 31: 1285–1293.
5. Prenen JAC, de Klerk JMH, van het Schip AD, van Rijk PP. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.J Nucl Med 1991; 32: 2057–2060.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献